DK1157030T3 - Enchinocanidin/carbohydratkomplekser - Google Patents
Enchinocanidin/carbohydratkomplekserInfo
- Publication number
- DK1157030T3 DK1157030T3 DK00917703T DK00917703T DK1157030T3 DK 1157030 T3 DK1157030 T3 DK 1157030T3 DK 00917703 T DK00917703 T DK 00917703T DK 00917703 T DK00917703 T DK 00917703T DK 1157030 T3 DK1157030 T3 DK 1157030T3
- Authority
- DK
- Denmark
- Prior art keywords
- enchinocanidin
- complex
- carbohydrate
- carbohydrate complexes
- echinocandin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12269299P | 1999-03-03 | 1999-03-03 | |
PCT/US2000/005508 WO2000052037A1 (fr) | 1999-03-03 | 2000-03-02 | Complexes d'echinocandine/glucide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1157030T3 true DK1157030T3 (da) | 2003-12-22 |
Family
ID=22404173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00917703T DK1157030T3 (da) | 1999-03-03 | 2000-03-02 | Enchinocanidin/carbohydratkomplekser |
Country Status (18)
Country | Link |
---|---|
US (3) | US7041637B2 (fr) |
EP (1) | EP1157030B1 (fr) |
JP (1) | JP4272359B2 (fr) |
KR (1) | KR20020003864A (fr) |
CN (1) | CN1345333A (fr) |
AT (1) | ATE248187T1 (fr) |
AU (1) | AU772633B2 (fr) |
BR (1) | BR0008712A (fr) |
CA (1) | CA2362016A1 (fr) |
DE (1) | DE60004793T2 (fr) |
DK (1) | DK1157030T3 (fr) |
ES (1) | ES2204548T3 (fr) |
HK (1) | HK1040088B (fr) |
IL (1) | IL145187A0 (fr) |
PT (1) | PT1157030E (fr) |
RU (1) | RU2001126723A (fr) |
WO (1) | WO2000052037A1 (fr) |
ZA (1) | ZA200108004B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743777B1 (en) * | 1992-03-19 | 2004-06-01 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
CA2353930A1 (fr) | 1998-12-09 | 2000-06-15 | Eli Lilly And Company | Purification de composes cyclopeptidiques d'echinocandine |
AU771727B2 (en) | 1999-03-03 | 2004-04-01 | Eli Lilly And Company | Processes for making pharmaceutical oral ECB formulations and compositions |
KR20020003864A (ko) * | 1999-03-03 | 2002-01-15 | 피터 지. 스트링거 | 에키노칸딘/탄수화물 착물 |
ATE338060T1 (de) | 1999-03-03 | 2006-09-15 | Lilly Co Eli | Bildung und anionenaustausch von inneren kristallinen ammoniumsalzen des echinocandins b |
WO2000051564A1 (fr) | 1999-03-03 | 2000-09-08 | Eli Lilly And Company | Formulations pharmaceutiques d'echinocandine contenant des tensioactifs formant des micelles |
US6482847B2 (en) * | 2000-10-03 | 2002-11-19 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
JP2005053782A (ja) * | 2001-08-31 | 2005-03-03 | Fujisawa Pharmaceut Co Ltd | 環状リポペプチド化合物の新規結晶 |
US6991800B2 (en) * | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
RU2284832C2 (ru) * | 2004-08-30 | 2006-10-10 | Николай Александрович Киселев | Антимикробная композиция для перорального введения |
KR101163160B1 (ko) * | 2006-03-07 | 2012-07-17 | 드리테 파텐트포트폴리오 베타일리궁스게젤샤프트 엠베하 운트 코. 카게 | 보존제의 가용화물 및 이들의 제조 방법 |
EP2012788A4 (fr) * | 2006-04-18 | 2010-05-26 | Ekr Therapeutics Inc | Compositions en bolus iv pre-melangees pretes a l'emploi et procedes d'utilisation |
US9394340B2 (en) | 2009-03-24 | 2016-07-19 | Cadila Healthcare Limited | Purification process for lipopeptides |
CN102614491B (zh) | 2011-01-31 | 2014-04-16 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途 |
CN102614492B (zh) * | 2011-01-31 | 2013-12-11 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物 |
CN102627689B (zh) * | 2012-03-30 | 2014-08-06 | 上海天伟生物制药有限公司 | 一种环肽类化合物的水合物及其制备方法和用途 |
PL3058958T3 (pl) | 2015-02-23 | 2019-02-28 | Selectchemie Ag | Kompozycja anidulafunginy |
CN110339341A (zh) * | 2018-04-03 | 2019-10-18 | 江苏恒瑞医药股份有限公司 | 一种达托霉素或其盐的组合物 |
KR20210076040A (ko) * | 2018-10-11 | 2021-06-23 | 임브리아 파마슈티칼스, 인크. | Tca 회로 중간체 및 그의 사용 방법 |
CN109574811B (zh) * | 2018-11-22 | 2021-12-24 | 中山大学 | 一种阿尼芬净侧链中间体对戊氧基三联苯甲酸的制备方法 |
CN116903706B (zh) * | 2023-06-13 | 2024-05-17 | 深圳市祥根生物有限公司 | 一种棘白菌素类药物及其制备方法和用途 |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US151474A (en) * | 1874-06-02 | Improvement in corn-shellers | ||
US54981A (en) * | 1866-05-22 | Improvement in nail-machines | ||
US161176A (en) * | 1875-03-23 | Improvement in heaters for cheese-vats | ||
US3293482A (en) | 1962-06-21 | 1966-12-20 | Rca Corp | Plural output traveling wave tube |
JPS5134916B2 (fr) | 1974-03-06 | 1976-09-29 | ||
DE2803581A1 (de) | 1978-01-27 | 1979-08-02 | Sandoz Ag | Derivate des tetrahydro-echinocandin b |
US4304716A (en) | 1979-12-13 | 1981-12-08 | Eli Lilly And Company | S 31794/F-1 Nucleus |
CA1183127A (fr) | 1979-12-13 | 1985-02-26 | Manuel Debono | Preparation de derives de noyaux de peptides cycliques |
CA1170598A (fr) | 1979-12-13 | 1984-07-10 | Bernard J. Abbott | Methode de preparation de noyaux peptidiques cycliques |
US4293483A (en) * | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4299763A (en) | 1979-12-13 | 1981-11-10 | Eli Lilly And Company | A-30912B Nucleus |
US4320052A (en) | 1979-12-13 | 1982-03-16 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4293489A (en) | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4293482A (en) | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | A-30912A Nucleus |
US4348384A (en) | 1980-10-17 | 1982-09-07 | Dainippon Pharmaceutical Co., Ltd. | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
US4393489A (en) * | 1981-03-30 | 1983-07-12 | Rca Corporation | Audio processor for single, channel, matrixed two-channel and un-matrixed two-channel signals |
US5141674A (en) | 1984-03-08 | 1992-08-25 | Phares Pharmaceutical Research N.V. | Methods of preparing pro-liposome dispersions and aerosols |
US4876241A (en) * | 1987-05-22 | 1989-10-24 | Armour Pharmaceutical Company | Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants |
US5166135A (en) | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
DK173802B1 (da) | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
AU617541B2 (en) | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US4927831A (en) | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US5202309A (en) | 1989-06-30 | 1993-04-13 | Merck & Co., Inc. | Antibiotic cyclopeptide fermentation product |
JPH03240727A (ja) | 1990-02-15 | 1991-10-28 | Toyo Jozo Co Ltd | ニューモシスチス・カリニ肺炎治療剤 |
CA2037957A1 (fr) | 1990-03-12 | 1991-09-13 | Merck & Co., Inc. | Composes de cyclohexapeptides n-acyles |
GB2241956A (en) | 1990-03-16 | 1991-09-18 | Merck & Co Inc | N-acylated cyclohexapeptide compounds |
IE910892A1 (en) | 1990-03-19 | 1991-09-25 | Merck & Co Inc | Lipopeptide compounds |
IL97347A0 (en) | 1990-03-19 | 1992-05-25 | Merck & Co Inc | Lipopeptide derivatives and antimicrobial compositions containing them |
US5330973A (en) | 1990-03-19 | 1994-07-19 | Merck & Co., Inc. | Lipopeptide derivatives |
US5386009A (en) | 1990-03-19 | 1995-01-31 | Merck & Co. Inc. | Lipopeptide derivatives |
US5049546A (en) | 1990-03-19 | 1991-09-17 | Merck & Co., Inc. | Antibiotic agents |
US5310726A (en) | 1990-03-19 | 1994-05-10 | Merck & Co., Inc. | Lipopeptide compounds |
ES2089133T3 (es) | 1990-06-07 | 1996-10-01 | Lilly Co Eli | Desacilasa de lipopeptidos. |
IL98506A (en) | 1990-06-18 | 1996-09-12 | Fujisawa Pharmaceutical Co | Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them |
US5198421A (en) | 1991-04-26 | 1993-03-30 | Merck & Co., Inc. | Phosphorylated cyclic lipopeptide |
EP0486011A3 (en) | 1990-11-16 | 1992-07-15 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical composition against pneumocystis carinii |
US5369093A (en) | 1991-03-15 | 1994-11-29 | Merck & Co., Inc. | Lipopeptide derivatives |
US5993805A (en) | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
US5233023A (en) | 1991-07-30 | 1993-08-03 | Merck & Co., Inc. | Process for phosphate ester compounds of certain cyclohexapeptides |
JPH05271097A (ja) | 1991-10-07 | 1993-10-19 | Asahi Chem Ind Co Ltd | アクレアシン類の可溶化剤および医薬組成物 |
MY136593A (en) | 1992-03-19 | 2008-10-31 | Lilly Co Eli | Cyclic peptide antifungal agents and process for preparation thereof |
US6743777B1 (en) | 1992-03-19 | 2004-06-01 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
US5965525A (en) * | 1992-03-19 | 1999-10-12 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US6384013B1 (en) | 1992-03-19 | 2002-05-07 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
EP0589074B1 (fr) * | 1992-09-22 | 2001-11-21 | Takeo Dr. Takayanagi | Complexes d'hydrates de carbone pour la destruction de cellules cancéreuses |
JPH06172205A (ja) | 1992-12-11 | 1994-06-21 | Asahi Chem Ind Co Ltd | アクレアシン類含有脂肪乳剤 |
US6268338B1 (en) | 1993-04-30 | 2001-07-31 | Merck & Co., Inc. | Cyclohexapeptidyl amine compounds |
JPH09500103A (ja) | 1993-05-04 | 1997-01-07 | メルク エンド カンパニー インコーポレーテッド | シクロヘキサペプチジルアミノアルキルエーテル |
IS1796B (is) | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
US5541160A (en) | 1994-04-04 | 1996-07-30 | Merck & Co., Inc. | Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5646111A (en) | 1995-04-07 | 1997-07-08 | Eli Lilly And Company | Cyclic peptide antifungal Agents |
US5618787A (en) | 1995-05-26 | 1997-04-08 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5786325A (en) | 1995-05-26 | 1998-07-28 | Eli Lilly And Company | Cyclic peptide antifungal agents and methods of making and using |
US5629290A (en) | 1995-05-26 | 1997-05-13 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5652213A (en) | 1995-05-26 | 1997-07-29 | Eli Lilly And Company | Cyclic peptide antifungal agents |
GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
US5629289A (en) | 1995-07-25 | 1997-05-13 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
US5693611A (en) | 1996-02-01 | 1997-12-02 | Eli Lilly And Company | Cyclic peptide antifungal agents |
JP2001503015A (ja) | 1996-02-01 | 2001-03-06 | イーライ・リリー・アンド・カンパニー | 環状ペプチド抗真菌剤 |
US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5696084A (en) | 1996-08-16 | 1997-12-09 | Abbott Laboratories | Amino-lipopetide antifungal agents |
JP2001507701A (ja) | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティック・システムズ・インコーポレーテッド | 親水性賦形剤を有する疎水性薬剤の溶液を噴霧乾燥するための方法及びその方法によって作製された組成物 |
AU8687798A (en) | 1997-08-04 | 1999-02-22 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5972996A (en) | 1997-08-22 | 1999-10-26 | Merck & Co., Inc. | 4-cyano-4-deformylsordarin derivatives |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
EP0931834A3 (fr) | 1997-12-23 | 2002-06-26 | Eli Lilly And Company | Domaine de liaison d'echinocandinl de la 1,3-beta-glucane synthase |
US6323176B1 (en) | 1998-02-25 | 2001-11-27 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US6284282B1 (en) | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
US6423345B2 (en) | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
US6451349B1 (en) | 1998-08-19 | 2002-09-17 | Quadrant Healthcare (Uk) Limited | Spray-drying process for the preparation of microparticles |
ES2233070T3 (es) | 1998-08-20 | 2005-06-01 | ELI LILLY & COMPANY | Sintesis de analogos peptidicos ciclicos modificados en el anillo. |
EP1107982B1 (fr) | 1998-08-28 | 2004-05-19 | Eli Lilly & Company | Complexes reversibles du bore de peptides cycliques contenant des groupes 1,2-(cis)-diol |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
CA2353930A1 (fr) | 1998-12-09 | 2000-06-15 | Eli Lilly And Company | Purification de composes cyclopeptidiques d'echinocandine |
WO2000035945A1 (fr) | 1998-12-16 | 2000-06-22 | Eli Lilly And Company | Agents antifongiques de peptide cyclique possedant un substituant sucre |
CA2354056A1 (fr) | 1998-12-16 | 2000-06-22 | James Andrew Jamison | Agents antifongiques de peptide cyclique |
US20030104048A1 (en) | 1999-02-26 | 2003-06-05 | Lipocine, Inc. | Pharmaceutical dosage forms for highly hydrophilic materials |
WO2000051564A1 (fr) | 1999-03-03 | 2000-09-08 | Eli Lilly And Company | Formulations pharmaceutiques d'echinocandine contenant des tensioactifs formant des micelles |
KR20020003864A (ko) | 1999-03-03 | 2002-01-15 | 피터 지. 스트링거 | 에키노칸딘/탄수화물 착물 |
AU771727B2 (en) | 1999-03-03 | 2004-04-01 | Eli Lilly And Company | Processes for making pharmaceutical oral ECB formulations and compositions |
ATE338060T1 (de) | 1999-03-03 | 2006-09-15 | Lilly Co Eli | Bildung und anionenaustausch von inneren kristallinen ammoniumsalzen des echinocandins b |
US6258821B1 (en) | 1999-04-26 | 2001-07-10 | Medimmune Oncology, Inc. | Compositions comprising trimetrexate and methods of their synthesis and use |
WO2003018051A1 (fr) | 2001-08-27 | 2003-03-06 | Vic Jira | Composition antifongique |
US6991800B2 (en) | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
-
2000
- 2000-03-02 KR KR1020017011234A patent/KR20020003864A/ko not_active Application Discontinuation
- 2000-03-02 DE DE60004793T patent/DE60004793T2/de not_active Expired - Lifetime
- 2000-03-02 IL IL14518700A patent/IL145187A0/xx unknown
- 2000-03-02 WO PCT/US2000/005508 patent/WO2000052037A1/fr active IP Right Grant
- 2000-03-02 RU RU2001126723/04A patent/RU2001126723A/ru not_active Application Discontinuation
- 2000-03-02 AT AT00917703T patent/ATE248187T1/de not_active IP Right Cessation
- 2000-03-02 CN CN00805697A patent/CN1345333A/zh active Pending
- 2000-03-02 ES ES00917703T patent/ES2204548T3/es not_active Expired - Lifetime
- 2000-03-02 DK DK00917703T patent/DK1157030T3/da active
- 2000-03-02 JP JP2000602261A patent/JP4272359B2/ja not_active Expired - Lifetime
- 2000-03-02 EP EP00917703A patent/EP1157030B1/fr not_active Expired - Lifetime
- 2000-03-02 PT PT00917703T patent/PT1157030E/pt unknown
- 2000-03-02 AU AU38635/00A patent/AU772633B2/en not_active Ceased
- 2000-03-02 BR BR0008712-2A patent/BR0008712A/pt not_active IP Right Cessation
- 2000-03-02 CA CA002362016A patent/CA2362016A1/fr not_active Abandoned
-
2001
- 2001-08-29 US US09/942,458 patent/US7041637B2/en not_active Expired - Lifetime
- 2001-09-28 ZA ZA200108004A patent/ZA200108004B/xx unknown
-
2002
- 2002-03-11 HK HK02101828.4A patent/HK1040088B/zh not_active IP Right Cessation
-
2005
- 2005-08-30 US US11/216,773 patent/US7550428B2/en not_active Expired - Fee Related
-
2009
- 2009-05-21 US US12/469,724 patent/US8022033B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2362016A1 (fr) | 2000-09-08 |
BR0008712A (pt) | 2001-12-26 |
AU3863500A (en) | 2000-09-21 |
EP1157030A1 (fr) | 2001-11-28 |
US20020160942A1 (en) | 2002-10-31 |
IL145187A0 (en) | 2002-06-30 |
ES2204548T3 (es) | 2004-05-01 |
JP4272359B2 (ja) | 2009-06-03 |
US20060111277A1 (en) | 2006-05-25 |
ATE248187T1 (de) | 2003-09-15 |
AU772633B2 (en) | 2004-05-06 |
KR20020003864A (ko) | 2002-01-15 |
HK1040088B (zh) | 2004-04-16 |
RU2001126723A (ru) | 2003-09-27 |
HK1040088A1 (en) | 2002-05-24 |
PT1157030E (pt) | 2004-01-30 |
EP1157030B1 (fr) | 2003-08-27 |
DE60004793T2 (de) | 2004-07-01 |
ZA200108004B (en) | 2003-06-25 |
US20090258820A1 (en) | 2009-10-15 |
US8022033B2 (en) | 2011-09-20 |
DE60004793D1 (de) | 2003-10-02 |
WO2000052037A8 (fr) | 2001-03-22 |
US7550428B2 (en) | 2009-06-23 |
JP2002539090A (ja) | 2002-11-19 |
CN1345333A (zh) | 2002-04-17 |
WO2000052037A1 (fr) | 2000-09-08 |
US7041637B2 (en) | 2006-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE248187T1 (de) | Echinocandin-kohlenhydrate-komplexe | |
DE69907977D1 (de) | Pyrrolobenzodiazepine | |
UY26082A1 (es) | Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica | |
AR030245A1 (es) | Composiciones de gel que contienen metronidazol | |
SE9503143D0 (sv) | New preparation | |
ECSP066314A (es) | Derivados piridilo y su uso como agentes terapéuticos | |
DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
UY25055A1 (es) | Formulaciones farmacéuticas que contienen voriconazol | |
NZ533179A (en) | Hydroxycucurbituril derivatives, their preparation methods and uses | |
DK1565471T3 (da) | Quionolinylpyrazoler | |
SE9900961D0 (sv) | Novel compounds | |
TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
EA200300406A1 (ru) | Фармацевтическая композиция дронедарона для парентерального введения | |
NO20013414D0 (no) | Ny anvendelse av melagatran | |
EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
EE200100066A (et) | Naatriumkloriidi kasutamine kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsetekõrvaltoimete vähendamiseks | |
TR200103125T2 (tr) | Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri. | |
SE0001916D0 (sv) | Novel formulation | |
DK1181300T3 (da) | 6-O-carbamatketolidderivater | |
ATE525605T1 (de) | Verbindungsstück | |
SE9902742D0 (sv) | New pharmaceutical formultion | |
DE60039122D1 (de) | 6-o-alkyl-2-nor-2-substituierte ketolidderivate | |
ES2124844T3 (es) | Palau'amina: un compuesto farmacologicamente activo aislado a partir de una esponja. | |
NO20015207L (no) | Anvendelse av antiprogestagener i kombinert terapi | |
MX9605312A (es) | Dipsipeptidos ciclicos antifungales. |